The funder backing a shareholder class action against the directors of pharmaceutical firm QRxPharma will not seek to profit from a $7 million settlement in order to bring about a better return for group members, a judge has been told.
Judge again rejects priority application in Crown Resorts class action
Mayfair’s Mawhinney hires Ashurst after lengthy ASIC submission
The director of the beleaguered Mayfair investment group, who has been self-represented in winding up proceedings by ASIC, has now entered into a late stage retainer with law firm Ashurst, with his barrister saying he could no longer manage the case on his own after the regulator filed a lengthy affidavit.
Government extends rule shielding companies, directors from COVID-19 class actions
The Morrison Government has extended a temporary change to the continuous disclosure rules to give companies more wriggle room in updating shareholders during the coronavirus pandemic by six months, saying the change had allowed shareholders to remain informed while preventing “opportunistic class actions”.